An Investigator Initiated Open Label Study Evaluating the Efficacy and Tolerability of Oral Apremilast for the Treatment of Nail Psoriasis

Trial Profile

An Investigator Initiated Open Label Study Evaluating the Efficacy and Tolerability of Oral Apremilast for the Treatment of Nail Psoriasis

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 02 Feb 2018

At a glance

  • Drugs Apremilast (Primary)
  • Indications Plaque psoriasis; Psoriasis
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Jan 2018 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.
    • 29 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2019.
    • 29 Jan 2018 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top